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G-rich sequences in DNA and RNA have a propensity to fold into stable secondary structures termed
G-quadruplexes. G-quadruplex forming sequences are widespread throughout the human genome,
within both, protein coding and non-coding genes, and regulatory regions. G-quadruplexes have
been implicated in multiple cellular functions including chromatin epigenetic regulation, DNA
recombination, transcriptional regulation of gene promoters and enhancers, and translation. Here
we will review the evidence for the occurrence of G-quadruplexes both in vitro and in vivo; their
role in neurological diseases including G-quadruplex-forming repeat expansions in the C9orf72 gene
in frontotemporal dementia and amyotrophic lateral sclerosis and loss of the G-quadruplex binding
protein FMRP in the intellectual disability fragile X syndrome. We also review mounting evidence
that supports a role for G-quadruplexes in regulating the processing or function of a range of
non-coding RNAs. Finally we will highlight current perspectives for therapeutic interventions that
target G-quadruplexes.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Strands of DNA or RNA that contain at least four stretches of
two or more adjacent guanine nucleotides, for example G2–
5XnG2–5XnG2–5XnG2–5Xn, where X can be up to seven spacer nucleo-
tides, are able to form structures termed G-quadruplexes. At the
core of these arrangements are cation-coordinated quartets of gua-
nine residues linked by Hoogsteen hydrogen bonds, as represented
in Fig. 1A, and reviewed in detail in [1–3]. G-quadruplexes can
either be intramolecular, forming from a single strand of DNA or
RNA, or intermolecular, forming from either two or four separate
nucleic acid strands Fig. 1B. G-quadruplexes can adopt either a par-
allel topology, in which the backbone of each nucleic acid strand of
the G-quadruplex run in the same direction, or an anti-parallel
topology in which the backbones run in opposing directions
Fig. 1B. RNA G-quadruplexes are normally restricted to a parallel
topology whereas DNA G-quadruplexes can form either type of
structure. A marked preference in RNA for an anti glycosidic bond
angle, is a consequence of steric constraints imposed by the C20
hydroxyl groups in RNA ribose sugars. This leads to a stable paralleltopology. These quadruplexes can be further classiﬁed according to
parameters such as the nucleotide sequence and size of spacer
tracts, inclusion of bases other than guanine in the quartet struc-
ture, the overall molecular geometry of the quadruplex and the
nature of the coordinating cations. We will review accumulating
evidence of the occurrence of G-quadruplexes in vitro and in vivo
and will provide examples of their roles within neurons both in
normal and pathological states. We will then review recent studies
that are revealing novel roles for G-quadruplexes in the regulation
of the non-coding transcriptome, an exciting new area of investiga-
tion with potential implications for understanding G-quadruplex
function genome-wide, and in the context of different diseases.
Finally, we will provide an overview of the latest progress in ther-
apeutic targeting of G-quadruplexes by small-molecule ligands.
2. Evidence for G-quadruplex formation in vitro
Pioneering studies by Gellert et al. [4] more than 50 years ago,
showed that the RNA nucleotide guanine monophosphate (GMP)
can self-associate to form four-stranded helices comprising layers
of hydrogen-bonded guanine (G) quartets stacked on the top of
each other, which can readily assemble into ﬁbres and gels in
water [5]. Later studies in the 1970s and 1980s illustrated
two important properties of these arrangements: (i) short
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Fig. 1. (A) Cation-coordinated quartets of guanine residues linked by Hoogsteen
hydrogen bonds form the core planar structure of each G-quadruplex. The attached
sugars impart chirality to the G-quartet with a head and a tail. The NH@CO
hydrogen bonds are oriented clockwise relative to the head of each quartet. (B) G-
quadruplexes can have different topologies: they can form intramolecularly
(unimolecular), either with a parallel or antiparallel conformation, or they can be
formed by two separate strands (bimolecular), either parallel or antiparallel. Finally,
G-quadruplexes can form from four different strands (tetramolecular).
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tures, as studied by NMR [6] and (ii) these structures are centrally
coordinated by cations. Alkali–metal ions were shown to be able to
stabilize the unfavourable electronic charge of the four oxygen
atoms exposed in the centre of an individual G-quartet, showing
a decreasing stability conferred by K+ > Na+ > Li+ [3]. The ion selec-
tivity is better explained by K+ ions being larger than Na+ or Li+, so
they ﬁt more effectively in between adjacent G-quartets [2].
Multiple supramolecular assemblies of G-quadruplex structures
have been demonstrated by NMR and light scattering to occur
in vitro. G-quartets formed from 50-GMP can self-organize into
columnar structures and multiple columns can also arrange in a
cholesteric phase or in a hexagonal liquid–crystalline phase [7].
2.1. DNA G-quadruplexes
Beyond these ﬁrst in vitro biophysical studies on self-assembly
of 50-GMP, it was in a series of later studies in the 1980s that
G-quadruplexes were suggested to be biologically functional struc-
tures. A key advance was the realisation that all chromosomal
telomeric regions contain repetitive G-rich sequences suitable for
quadruplex formation. These telomeric sequences have thus been
extensively studied for their ability to form G-quadruplexes and
have provided important structural and functional information.
Sen and Gilbert [8] provided evidence that G-quadruplexes formed
intermolecularly between pairs of chromosomes and proposed a
model in which G-quadruplex formation drives chromatid pairing
during meiosis. Sundquist and Klug [9] were amongst the ﬁrst to
show that telomeric repeats from Tetrahymena dimerize in asalt-dependent manner to adopt an antiparallel G-quadruplex
arrangement, which may be important for telomere recombina-
tion. The ﬁrst structural studies employed NMR of G-rich DNA
oligonucleotides and demonstrated that they fold into a parallel
G-quadruplex structure [10]. X-ray crystallographic studies further
characterized the different topologies of the G-quadruplexes
formed in vitro by short oligonucleotides. Haider et al. [11] showed
by crystallography that the DNA telomeric d(G4T4G4)2 repeats from
the ciliate Oxytricha form a K+-stabilized bimolecular
G-quadruplex, in which two hairpins join together into an
anti-parallel structure with thymidine loops at either end. Quite
different is the conformation obtained for the human telomeric
DNA d[AGGG(TTAGGG)3], which in the presence of K+ ions, was
shown to assume a parallel unimolecular G-quadruplex with
fold-back TTA loops [12], extending far away from the G-quartet
core, thus providing potential binding sites for telomere interact-
ing proteins. It differs fundamentally from the antiparallel folds
found by NMR studies on various human telomeric sequences
studied in dilute solution [13]. This structure was also substantially
different from a previous study of a distinct Tetrahymena telom-
eric DNA repeat sequence of d(TGGGGT), obtained in the presence
of Na+ ions, which was shown to form a parallel four-stranded
intermolecular G-quadruplex [14].
2.2. RNA G-quadruplexes
Much less is known about the topology of RNA G-quadruplex
structures, with a few exceptions. Deng et al. [15] determined
the X-ray crystallographic structure at subatomic resolution of
r(UGGGGU)4 in the presence of Sr2+ ions, and showed that it forms
a parallel G-quadruplex with each unit stacking on one another
with opposite polarity, resulting in a columnar arrangement. The
human telomeric RNA G-quadruplex has a parallel topology both
in the crystal and in solution, which is closely similar to the telom-
eric DNA G-quadruplex propeller-like arrangement [16,17]. The
CGG repeat within the 50-untranslated region of the Fragile X syn-
drome gene FMR1 was modelled using a d(GCGGT3GCGG) oligonu-
cleotide [18]. NMR showed that the sequence forms a
G-quadruplex through dimerization of two symmetric hairpins
held together by two canonical G-quartets in a sandwich-like
structure with two middle GCGC Watson–Crick base paired quar-
tets and with connecting T3 loops at opposite sides. This demon-
strated for the ﬁrst time that G-quadruplexes can form a mixed
assembly of Hoogsteen hydrogen bonded G-quartets and dimer-
ized Watson–Crick G.C base-pairs.
2.3. Hybrid DNA:RNA G-quadruplexes and R-loops
When transcription occurs, the newly synthesised transcript
still bound to the RNA polymerase holoenzyme can potentially
form a heteroduplex structure pairing with the non-template
DNA strand. This leads to formation of a DNA.RNA hybrid known
as an R-loop, which in turn affects transcription [19]. When the
DNA and RNA sequences involved in the R-loop formation contain
two or more adjacent guanines, they can potentially fold into an
intermolecular DNA:RNA hybrid G-quadruplex. A recent bioinfor-
matics analysis found that putative DNA:RNA hybrid
G-quadruplex (PHQs) are strongly biased towards the
non-template DNA strand and are mainly enriched within 1 kb
downstream of the transcription start site (TSS) [20], consistent
with their involvement in transcriptional regulation. PHQ forma-
tion requires as few as two G-tetrads instead of four or more as
in canonical intramolecular G-quadruplexes and were present in
more than 97% of human genes [21]. R-loops and hybrid
G-quadruplexes have been documented to occur in many different
contexts and have been ascribed different functions, such as a role
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the switch between mitochondrial genome transcription and repli-
cation [23]. More recently a role for R-loops has also been proposed
in different neurodegenerative diseases such as those caused by
repeat expansions in the C9orf72 [24,25] and FMR1 [26,27] genes.3. Evidence for G-quadruplex formation in vivo
The studies described above clearly demonstrate the existence
of G-quadruplexes in vitro. This section will focus on the smaller
number of studies that also support their presence in vivo.
Several independent lines of evidence support the existence and
functional relevance of G-quadruplexes in vivo, which can be
mainly summarized as (1) evidence of G-quadruplex speciﬁc heli-
cases, (2) in vivo NMR, (3) G-quadruplex speciﬁc antibodies and (4)
indirect functional evidence.
3.1. Evidence of G-quadruplex speciﬁc helicases
One of the earliest pieces of circumstantial evidence for the
existence of G-quadruplex structures in vivo, came in 2002, when
mutations in the dog-1 gene in Caenorhabditis elegans were shown
to cause multiple recurrent deletions of genomic DNA at the 30-end
of polyguanine stretches [28]. DOG-1, which stands for ‘‘deletions
in guanine-rich DNA’’, encodes for a G-quadruplex DNA helicase,
which is essential for resolving long stretches of polyguanine, espe-
cially those containing more than 18 consecutive dG/dC. The gk10
null mutation, caused by a premature stop codon, leads to break-
points either at the 50-end of poly(dC) or at the 30-end of
poly(dG). The mechanism is compatible with a failure in
lagging-strand DNA synthesis, which would require the DOG-1
helicase to unwind G-quadruplex structures that can readily form
on the non-template DNA strand, during replication. The human
homolog of DOG-1, called FANCJ/BRIP1, has also been shown to
regulate progression of DNA replication through resolution of
G-quadruplexes [29], as cells deﬁcient for FANCJ exhibit
G-quadruplex DNA instability similarly to the C. elegans dog-1
mutant, caused by replication stalling at G-quadruplexes. Other
eukaryotic DNA–RNA helicases have since been shown to be able
to either speciﬁcally unwind G-quadruplexes or to resolve
RNA:DNA hybrid R-loops. The Pif1 family of helicases, conserved
from bacteria to humans, regulate DNA replication through
G-quadruplexes, protecting the genome from DNA damage in the
vicinity of these motifs, which are prone to breakage [30,31]. A
more recent study showed that Pif1 monomers anchored at the
30-end of G-quadruplexes, are able to cyclically unwind DNA
G-quadruplexes, extruding them into a loop one nucleotide at a
time [32]. After a ﬁrst cycle of activity and following
G-quadruplex refolding, without dissociating from its site, Pif1
helicase is able to repeatedly unwind G-quadruplex DNA, even in
the presence of G-quadruplex-binding drugs [32]. DHX36, also
known as G4 resolvase 1 or RHAU, is another abundant
DNA-RNA helicase able to strongly bind and resolve both DNA
[33] and RNA G-quadruplex structures in mammalian cells [34].
A recent study offered a mechanistic view of how DHX36 works:
markedly different from the highly processive activity displayed
by Pif1 family helicases which remain stably attached to their sub-
strates preventing them from refolding, DHX36 activity is unpro-
cessive, as the helicase dissociates from the substrate after each
ATP hydrolysis event [35]. These two types of mechanism suggest
that different functions might be regulated through different
G-quadruplex helicases, or they can simply target different cate-
gories of target genes.
The overrepresentation of G-quadruplexes near transcription
start sites and the occurrence of transcription-induced formationof G-quadruplex structures strongly suggests that factors binding
and resolving those structures might well be associated with the
transcription apparatus. Recently two components of the general
transcription factor TFIIH, XPD and XPB have been shown by chro-
matin immunoprecipitation-sequencing (ChIP-Seq) to be preferen-
tially associated to G-quadruplex motifs along about 20% of human
genes [36]. Particularly XPD acts as a G-quadruplex DNA helicase
whereas XPB is a G4 DNA-binding protein, and both of them are
crucial for coordinating DNA damage checks and repair mecha-
nisms coupled to the opening of DNA during transcription [36].
DHX9/RNA helicase A represents an abundant cellular helicase
unwinding RNA G-quadruplexes and R-loops [37], much more efﬁ-
ciently than duplex DNA. By resolving those structures DHX9 has
been suggested to contribute to transcriptional activation and to
maintain genomic stability.
3.2. In cell-NMR
A recent approach called ‘‘in cell-NMR’’ has enabled the study of
not only proteins but also nucleic acids directly in the eukaryotic
environment [38]. G-quadruplex structures were directly deter-
mined with 13C and 15N NMR, by injecting different
radiolabelled-oligonucleotides into Xenopus oocytes [39].
3.3. G-quadruplex-speciﬁc antibodies
In a different approach to provide direct evidence of the in vivo
occurrence of G-quadruplexes, the production of speciﬁc antibod-
ies has been achieved, which enabled the direct imaging of the
intracellular distribution of G-quadruplex structures in different
cell types. A ﬁrst study by Schafﬁtzel and colleagues [40] generated
high-afﬁnity single-chain antibody fragments (scFv) against the
G-quadruplex d(T4G4) from Stylonychia telomeres, by ribosome
display from a human combinatorial antibody library. The Sty3
scFv was highly speciﬁc for parallel G-quadruplexes whereas a sec-
ond scFv (Sty49) bound both parallel and anti-parallel
G-quadruplexes. The latter antibody stained the ciliate macronu-
cleus, a large nuclear structure containing genes necessary for veg-
etative growth, arranged in about 108 telomere-capped
nanochromosomes, clearly demonstrating the occurrence of
telomeric G-quadruplexes within this compartment.
Furthermore, no speciﬁc staining was visible within the replication
band, a region where chromosome and telomere replication takes
place, suggesting that G-quadruplexes were resolved during repli-
cation [41].
More recently another murine monoclonal antibody (1H6) was
developed and showed a speciﬁc nuclear staining in human HeLa
cells, which was sensitive to DNAse treatment and showed an
increased intensity in response to increasing concentrations of
the G-quadruplex stabilizing agent TMPyP4 [42]. An increased
antibody staining was also observed in response to a deﬁciency
of the G-quadruplex DNA speciﬁc helicase FANCJ, suggesting a
prominent role for this helicase in unwinding DNA G-quadruplex
motifs [42]. This study also showed that whereas G-quadruplexes
in normal cells can be effectively unwound by helicase action, in
those cancer cells where FANCJ is mutated it was signiﬁcantly less
effective. Bifﬁ et al. [43,44] developed a G-quadruplex speciﬁc anti-
body (BG4) that enabled them to visualize cytoplasmic RNA
G-quadruplexes in human ﬁbroblasts for the ﬁrst time. Their
conformation-speciﬁc antibody [43] labelled both nuclear and
cytoplasmic foci, which were sensitive to either RNAse or DNAse
treatment respectively, demonstrating that these foci represent
bona ﬁde RNA and DNA G-quadruplex structures. Furthermore
the number of cytoplasmic RNA G-quadruplex foci increased when
cells were treated for 24 h with CarboxyPyridostatin, a ligand
speciﬁc for RNA G-quadruplexes [44].
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to show that G-quadruplexes modulate gene expression in vivo.
Fernando et al. [45] expressed a single chain antibody selective
for G-quadruplex DNA over double strand DNA (1HF) in HGC-27
human gastric carcinoma cells, and observed signiﬁcant expression
changes in large sets of genes, correlated with the presence of
putative G-quadruplexes. Therefore, based on both in cell-NMR
and G-quadruplex-speciﬁc antibodies generated by several inde-
pendent groups there is mounting evidence to support the pres-
ence of physiologically relevant G-quadruplexes in vivo.
G-quadruplex formation in vivo is also indirectly supported by evi-
dence obtained in studies of G-quadruplex-binding proteins and
the role of G-quadruplexes in non-coding RNA regulation, as dis-
cussed further below.
4. G-quadruplexes in neurological disorders
Two main categories of human diseases have shown an involve-
ment of G-quadruplex motifs: cancers and neurological disorders.
This suggests G-quadruplexes can play a physiological role that is
altered in disease states. A physiological role for G-quadruplexes
is supported by the non-random genomic distribution of
G-quadruplex motifs in the human genome [2,46,47], as well as
by the enrichment of G-quadruplex motifs within microsatellites
and regulatory elements in particular categories of genes [48–
50]. G-quadruplexes have been implicated in neurological diseases
via two distinct mechanisms: (i) through expansions of G-rich
sequences found to be causal of disease that are predicted to form
G-quadruplexes, and (ii) by mutations that affect the expression of
G-quadruplex binding proteins. These mechanisms are best
described for repeat expansions in C9orf72 and loss of the fragile
X mental retardation protein (FMRP) respectively, which we will
focus on here. In addition, several other neurodegenerative disease
genes contain G-rich repeat expansions that may also lead to
G-quadruplex formation (Table 1). Finally, the processing of speci-
ﬁc G-quadruplex-containing tRNAs has been shown to be neuro-
protective (Table 1) and this will also be discussed.
4.1. Expansions of G-quadruplex-forming repeats in C9orf72 causes
FTD and ALS
Amyotrophic lateral sclerosis (ALS) causes progressive muscle
weakness and spasticity due to motor neuron degeneration.
Frontotemporal dementia (FTD) manifests with changes in beha-
viour, language and personality, caused by degeneration of neu-
rons in the temporal and frontal lobes of the brain. Accumulating
evidence suggests that these two diseases form a continuum, with
a spectrum of phenotypic variants of the same pathological pro-
cess, which involves altered homeostasis of key master regulators
like the DNA–RNA binding proteins TDP-43 and FUS [74,75].Table 1
Genes with putative G-quadruplex repeats involved in neurological disorders.
Gene Position Repeat
C9orf72 Intron 1 GGGGCC 500 to several thousand repeats
CSTB Promoter CGGGGCGGGGCG > 40 repeats
FMR1 50-UTR CGG 55–200 pre-mutation > 200 full-mutatio
NOP56 Intron 1 GGCCTG 25 to 2500 repeats
PRNP Coding exon CCTCATGGTGGTGGCTGGGGGCAG 4–14 octap
repeat insertions (OPRI)
tiRNAAla
tiRNACys
Non-coding 50-tRNA
fragments
GGGGGTGTAGCTCAG-TGGTAGAGCGCGTGC s
Note: References 18, 51-54, 61-63 and 73 provide direct evidence for G-quadruplex form
potential to form G-quadruplexes.Further support to the common pathogenic process involved in
ALS-FTD came in 2011 with the discovery that sporadic and famil-
ial cases of both disorders are caused by an expansion of a GGGGCC
(G4C2) repeat within the ﬁrst intron of the C9orf72 gene [55,56]
(Fig. 2A), termed C9FTD/ALS. Indeed the C9orf72 (G4C2) repeat
expansion is now known to be the most common genetic
cause of both FTD and ALS [76]. Healthy individuals carry an
average of 2 repeats, with 90% having 8 or less [77]. In ALS and
FTD patients the G4C2 repeats range between 500 and several
thousand units [78,79]. We have shown that G4C2 repeat RNA
folds into a very stable parallel G-quadruplex [51] (Fig. 2B),
which was conﬁrmed by other groups [52,54]. Furthermore,
Reddy et al. [54] showed that r(G4C2) but not r(G2C4) RNA repeats
form both uni- and multimolecular G-quadruplexes. Because
multimolecular-G-quadruplexes formed more efﬁciently with
longer repeats, the authors hypothesized that RNA–RNA interac-
tions mediated through G-quadruplexes might help explain tran-
script aggregation and RNA foci formation in C9FTD/ALS [54].
More recently it was demonstrated that d(G4C2) repeats also give
rise to a mixed parallel-antiparallel G-quadruplex topology at the
DNA level [52,53]. In combination, these ﬁndings have profound
implications for understanding disease mechanism, implicating a
potential role of G-quadruplexes in C9orf72 both at the DNA and
RNA levels.
4.2. C9orf72 repeat RNAs sequester speciﬁc proteins
Several studies have implicated G-quadruplexes in various
aspects of cellular regulation and maintenance, ranging from
recombination to transcription, splicing, RNA localization and
translation [2,80,81]. Haeusler and colleagues [52] showed that
expansion of G4C2 repeats in C9orf72 lead to formation of
DNA.RNA hybrids, known as R-loops, which stall RNA polymerase,
leading to lower levels of full-length C9orf72 transcripts and caus-
ing accumulation of abortive transcripts containing G-quadruplex
structures. The same repeat-containing transcripts were shown
to bind and sequester nucleolin in a conformation-dependent man-
ner [52] (Fig. 2C). Nucleolin was mislocalized in patient-derived
cells carrying the expansion, and nucleolar function was impaired
in the same patient cells [52] (Fig. 2C). Nucleolar stress was reca-
pitulated in wild-type cells overexpressing expanded G4C2 repeats,
suggesting that an impairment in ribosomal RNA biogenesis and
other nucleolar functions might occur early in C9FTD/ALS [52].
These results illustrated the importance of the G-quadruplex con-
formation of C9orf72 DNA/RNA expanded repeats as a determinant
of the pathogenic mechanism in disease. RNA foci composed of
sense and antisense G4C2 repeat RNA have been found by several
independent studies in post-mortem brain regions and spinal cord
of C9FTD/ALS patients [56,82–88] (Fig. 2C). Using in vitro biochem-
ical assays, G4C2 RNA repeats were shown to sequester severalDisease References
Frontotemporal dementia/amyotrophic lateral
sclerosis
[51–56]
Progressive myoclonus epilepsy type 1 (EPM1) [57–59]
n Fragile X-associated tremor/ataxia syndrome
Fragile X syndrome,
[18,60–63]
Spinocerebellar ataxia (SCA36) [64–66]
eptide Familial Creutzfeldt–Jakob disease (CJD) [67–70]
ingle copy Amyotrophic lateral sclerosis (ALS) [71–73]
ation; the other references conﬁrm the presence of G-rich repeats, which have the
Fig. 2. (A) The three main isoforms of C9orf72 transcripts start from two alternative sites (Exon 1a and Exon1b) and the G4C2 repeat lies between them. Introns are drawn as
lines, untranslated exons as white boxes and coding exons as grey boxes respectively. (B) On a wild-type allele, with 2–8 G4C2 repeats, C9orf72 transcription occurs at a
normal basal level. Expansion of the G4C2 repeats to a pathological range leads to the formation on the non-template strand of a large ‘‘G-quadruplex island’’, with each
individual G-quadruplex (abbreviated to G4) adopting an antiparallel conformation. Transcription from the template strand leads to production of RNA transcripts containing
many G-quadruplexes in a parallel conformation. Transcription takes place bidirectionally, generating antisense transcripts, which likely form hairpin or i-motif structures,
potentially in equilibrium with G-quadruplexes of low stability, although this remains hypothetical at present. (C) Transcripts accumulate in RNA foci in the nucleus,
sequestering several RNA-binding proteins. Nucleolin binds speciﬁcally to the G-quadruplex sense transcripts in the nucleolus, altering biogenesis of ribosomal RNA (rRNA)
[52]. (D) Both sense and antisense transcripts are exported to the cytoplasm where they are subject to repeat-associated non-ATG (RAN) translation in all frames, resulting in
5 different dipeptide-repeat (DPR) proteins. DPR proteins are prone to aggregate forming both cytoplasmic and nuclear inclusions (C and D). Particularly, arginine-rich DPR
proteins, recently shown to confer neurotoxicity [98], also accumulate in the nucleolus [99], further contributing to nucleolar stress.
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SC35), the mRNA export receptor ALYREF, the single strand DNA
binding protein Pur-alpha, the RNA-binding protein hnRNPA3
and the RNA editing factor ADARB2, which have been extensively
reviewed in [89]. Collectively these studies suggest that expanded
G-quadruplex tracts in C9orf72 may cause disease through an RNA
gain of function mechanism [90].
4.3. C9orf72 repeats undergo repeat-associated non-ATG translation
Amajor advance in the repeat expansion ﬁeld came in 2011with
the discovery that expanded repeat sequences can be directly trans-
lated through a non-canonical mechanism known as
repeat-associated non-ATG (RAN) translation. This phenomenon,
originally described for the CAG repeats present in human
spinocerebellar ataxia type 8 (SCA8) and myotonic dystrophy type
1 (DM1) [91], was more recently shown to occur on C9orf72 G4C2
expanded repeats [87,92] and on fragile-X tremor ataxia syndrome
CGG repeats [93]. The C9orf72 expanded repeats are subject to
RAN translation giving rise to dipeptide repeat proteins (DPR) in
all possible frames [60,61,86,94,95], on both strand orientations,
and independently from translation of the host protein-coding gene
(Fig. 2D). All DPR proteins give rise to neuronal cytoplasmic inclu-
sions (Fig. 2D) in patient brain [60–65], and frequently colocalize
with p62-positive, TDP-43 negative inclusions [64,65,96,97].
Expression of DPRs in Drosophila neurons [98,99] or primary rodent
neuronal cultures [96,97] causes profound toxicity, implicating
DPRs in disease pathogenesis. This raises the critical as yet unan-
swered question whether the r(G4C2) G-quadruplexes structures
play a role in the initiation or inhibition of RAN translation. This pos-
sibility is supported by the known role of G-quadruplexes in affect-
ing translation as discussed in the sections below. DPRs are also
generated from r(C4G2) antisense transcripts, whose structure is
not yet determined, but could form G-quadruplexes of lower stabil-
ity, characterized by only two G-tetrads. It is also possible for both
sense and antisense repeats that other alternative secondary struc-
tures potentially in equilibrium with G-quadruplexes, might play a
role in controlling RAN translation. Indeed the ﬁrst description of
RAN translation suggested hairpin structures may mediate transla-
tion [91]. In conclusion, the G4C2 repeat in C9orf72 could play a role
in disease pathogenesis both at the level of RNA toxicity through
sequestering RNA-binding proteins and potentially at the protein
level through either facilitating or hindering RAN translation.
4.4. FMRP is a G-quadruplex binding protein implicated in neurological
disease
In 1991 Verkerk et al. [100] identiﬁed the gene responsible for
Fragile X syndrome (FXS), called Fragile X Mental Retardation gene
1 (FMR1, shown in Fig. 3A). FXS is a common form of inherited
intellectual disability (ID), with an incidence of 1 in 5000 males
[101]. Postmortem examination revealed that FXS patients’ neu-
rons have dense, immature dendritic spines [71]. Most cases of
FXS are caused by a large expansion of a CGG repeat in the
50-UTR of FMR1, which causes methylation and silencing of FMR1
and the lack of FMRP protein expression [102,103] (Fig. 3B).
FMRP is a widely expressed protein enriched in brain and testes
[77] and is a well characterized G-quadruplex binding protein. Its
involvement in disease has been hypothesized to be linked to alter-
ations in protein translation and alterations in RNA localization. In
neurons FMRP is mainly cytoplasmic and localised in the cell body,
dendrites and synapses [104,105] where it is translated in response
to neurotransmitter release [106]. FMRP is a sequence-speciﬁc
mRNA-binding protein that represses translation of a subset of
dendritically localized mRNAs, corresponding to about 4% of all
brain mRNAs [107]. About 400 different mRNAs have been foundto be potential targets of FMRP [108,109], although only 14 of
these targets have been experimentally validated [60]. FMRP rec-
ognizes speciﬁc secondary structures in its target mRNAs, the most
frequent of which is a G-quadruplex [110]. FMRP binds
G-quadruplexes in vitro through its C-terminal RGG box domain
[111] (Fig. 3C), and most of its validated targets contain a putative
G-quadruplex motif in their mRNA. Arginine methylation of the
RGG box domain reduces afﬁnity of FMRP for its G-quadruplex
target mRNAs [111]. Biochemical assays conﬁrmed that
G-quadruplexes mediate binding of FMRP to its own Fmr1 mRNA
(due to a G-quadruplex in exon 13, outside of the CGG repeat see
Fig. 3A) [112], as well as to MAP1B [113] and Sema3F [114].
FMRP coimmunoprecipitates with a G-rich element in amyloid
precursor protein (APP) mRNA [115], and represses its translation.
FMRP has been shown to bind and regulate stability of the
post-synaptic mRNA PSD-95 [116], although it is not clear whether
its binding is entirely mediated through the PSD-95 G-quadruplex
motif.4.5. FMRP binding to RNA G-quadruplexes directly affects translation
FMRP usually inhibits translation of its target mRNAs by block-
ing initiation of translation [117,118] (Fig. 3D), causing ribosome
stalling [119] (Fig. 3C), interacting with the RNAi pathway [120–
122] (Fig. 3D), or a combination of the three. Particularly intriguing
is the hypothesis that FMRP binding to G-quadruplexes may stabi-
lize their structures and provide a steric block to ribosome elonga-
tion. In response to synaptic activation FMRP is dephosphorylated
leading to release from its target mRNAs and subsequent derepres-
sion of translation of speciﬁc synaptic proteins, allowing their
expression to occur locally at speciﬁc times and thus having a crit-
ical role in dendritic local protein synthesis and synaptic plasticity
[123,124]. In the absence of FMRP, mGluR-mediated Long Term
Depression (mGluR-LTD) signaling is overactive, and synaptic plas-
ticity is reduced [125]. This molecular dysregulation is the major
cause of the cognitive deﬁcits observed in FXS patients [126].
FMRP has been also reported to bind to a subset of its target
mRNAs through either U-rich stretches [127] or a tripartite
stem-loop structure known as Sod1 stem loops interacting with
FMRP (SoSLIP) [128]. SoSLIP interacts with FMRP’s C-terminal
region, encompassing the RGG box, and competes for binding with
the G-quadruplex structure [128]. Surprisingly both SoSLIP and
U-stretches motifs when bound to FMRP lead to translation activa-
tion of the host target gene [127,128]. This suggests that FMRP–
RNA interactions will either activate or repress translation depend-
ing on the type of structure FMRP is binding to, it’s proximal or dis-
tal position, and its phosphorylation status. Overall, all these
studies on G-quadruplex–FMRP interactions strongly highlight
the importance of putative G-quadruplex motifs in the regulation
of local translation of hundreds of key mRNAs in neuronal cells
and its dysregulation as one major patho-mechanism in FXS.4.6. FMRP binding to RNA G-quadruplexes is required for neuronal
trafﬁcking of speciﬁc mRNAs
A recent study proposed a role for G-quadruplex RNA structural
elements as a signal for neurite mRNA targeting. Subramanian
et al. [129] found that around 30% of well-known dendritic
mRNAs contain a G-quadruplex motif in their 30-UTR and this motif
is necessary and sufﬁcient to confer neurite localization to GFP
reporters containing the 30-UTR of either PSD-95 or CaMKIIa in
transfected mice primary cortical neurons [129]. This ﬁnding raises
the intriguing possibility that G-quadruplexes formed by repeat
expansion in neurological diseases may lead to altered localization
of the mRNAs in which they reside.
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A
Fig. 3. (A) A representative isoform of the FMR1 gene is shown, with the CGG repeat located within the 50-UTR and a G-quadruplex motif within exon 13 [179]. (B) Wild-type
alleles with less than 54 CGG repeats are transcribed at a basal level and result in normal FMRP protein levels. Premutation carriers bearing an intermediate number of
repeats (55–200 units), which is associated with fragile X tremor ataxia (FXTAS) in males or fragile X-related primary ovarian insufﬁciency (FXPOI) in females, exhibit
increased FMR1 transcription, but slightly diminished FMRP translation [180]. FXTAS may be caused by RNA toxicity, toxic RAN translation products, or both. Full expansion
with more than 200 CGG repeats, results in abolishment of FMR1 transcription and translation due to an induction of DNA methylation and epigenetic heterochromatin
modiﬁcations on fully expanded alleles. Lack of FMRP leads to the development of fragile X syndrome. FMRP binds to parallel RNA G-quadruplexes in several target
transcripts, mainly within 30-UTRs. FMRP, in its phosphorylated state, is able to repress translation either alone by stalling ribosomes in the elongation stage (C), or recruiting
other co-factors such as the co-repressor CYFIP or miRNA-loaded RISC (D), and preventing assembly of a ternary complex between cap-bound initiation factors eIF4E and
eIF4G and the poly(A)-binding protein (PABP). (E) FMRP regulates trafﬁcking of hundreds of mRNA from the cell body to the dendrites. Phosphorylated FMRP binds to G-
quadruplex in dendritic transcripts, maintaining them in a repressed state, to prevent their premature translation during trafﬁcking. Upon stimulation of metabotropic
glutamate receptors (mGluR), FMRP is dephosphorylated on Ser499 and polysomes are released from repression, to allow local synaptic translation to occur [126].
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Intriguingly there is evidence that the FMR1 CGG DNA repeats
can readily form both hairpins [130–133] and a parallelbimolecular G-quadruplex structure [18,61–63], which are likely
in equilibrium. The role of CGG repeat DNA G-quadruplexes in
the pathogenesis of FXS is unclear as the disease is clearly caused
by a loss of FMRP, but they may play a role in FXTAS, where smaller
Table 2
G-quadruplexes in non-coding RNAs relevant to nervous system biology.
ncRNA Interacting region Target G-quadruplex (G4) motifs Biological process/function Reference
Mir-92b Pre-miRNA G4 regulating precursor maturation Brain cortical development, deregulated in brain tumors [145]
Mir-1292 Intron1 of NOP56 G4 regulating precursor transcription Spinocerebellar ataxia type 36 (SCA36) [64]
Mir-125a 30-UTR of PSD-95 G4 RNA seed region accessibility Role in translation regulation of dendritic PSD-95 mRNA [146]
Piwi-RNAs Pre-piRNAs G4 pre-piRNAs maturation regulated by
MOV10L1 helicase
Piwi-associated RNA biogenesis [147]
D4Z4 satellite Chr 4q35 subtelomeric
region
G4 DNA regulating chromatin state Dysregulated in Facio-Scapulo-Humeral Muscular
Dystrophy (FSHD)
[148]
rDNA Nucleolus G4 rDNA Nucleolar activity and dynamics [141]
TERRA lncRNA Telomeres G4 RNA telomere Telomere maintenance [80]
TERC RNA Telomeres G4 RNA component of telomerase Telomere replication and maintenance [80]
1660 R. Simone et al. / FEBS Letters 589 (2015) 1653–1668expansions of the d(CGG) repeat allow for its transcription,
although resulting in the production of a lower level of FMRP pro-
tein [60].
4.8. A neuroprotective role for G-quadruplex containing tiRNAs
G-quadruplexes have been shown to be involved not only in
causing neurodegeneration but also in being able to confer neuro-
protection. Particularly interesting is the case of the angiogenin
(ANG) gene and its target RNAs. ANG possesses ribonuclease A
activity that is responsible for processing of tRNA transcripts
[134,135], leading to translation inhibition. Rare missense muta-
tions in ANG result in loss of either ribonucleolytic activity or
nuclear translocation, or both functions, and have been suggested
to cause ALS [136] and Parkinson’s disease (PD) [137]. Stress sig-
nalling can activate ANG ribonuclease activity leading to cleavage
of tRNAs within anticodon loops, generating tRNA-derived
stress-induced fragments (tiRNAs) [71,72]. Sprciﬁc tiRNA frag-
ments (tiRNAAla, tiRNACys) inhibit translation initiation by displac-
ing the interaction of the initiation factors eIF4G/eIF4A or eIF4F
with cellular transcripts. This sequence of events is neuroprotec-
tive for cells under stress. A 50-terminal G-quadruplex forming oli-
gomeric G-rich motif within the tiRNA is required for the
tiRNA-mediated protein synthesis inhibition and subsequent neu-
roprotective stress granule (SG) assembly [72,73]. Similarly DNA
analogs of tiRNAAla and tiRNACys enter cells, inhibit translation,
promote formation of SGs, and confer neuroprotection to motor
neurons exposed to stresses such as excitotoxicity and serumwith-
drawal [73]. However, it should be noted that prolonged inhibition
of translation ultimately becomes neurotoxic in several neurode-
generative disease paradigms [138,139] indicating that translation
control must be delicately balanced to promote neuronal survival.
5. Novel roles for G-quadruplexes in the regulation of non-
coding RNAs
The human genome contains about 376000 different potential
G-quadruplex-forming sequences, which follow a non-random dis-
tribution [48,49]. G-quadruplexes are enriched at telomeres where
they inhibit the activity of the telomerase reverse transcriptase,
and regulate telomere length through the action of speciﬁc
G-quadruplex-binding proteins. G-quadruplexes are particularly
enriched in human promoter regions [140], where they contribute
to the regulation of transcription. Although at a genome wide level
G quadruplexes are not increased in 30UTRs, when considering
neuronal transcripts that are transported to neuronal processes,
an enrichment in G-quadruplexes is found. A higher frequency of
G-quadruplexes is observed in certain categories of genes like ribo-
somal DNA repeats [141], immunoglobulin genes and oncogenes in
comparison to tumor suppressors [142]. Less is known about the
occurrence of G-quadruplex structures in the non-coding tran-
scriptome. In Table 2 we summarize current studies that arestarting to reveal novel roles for G-quadruplexes in the function
and biogenesis of different classes of human non-coding RNAs
(ncRNAs), and show their potential involvement in disease.
Considering the abundance of studies on the role of
G-quadruplexes in telomeric repeat RNA (TERRA) and Telomerase
RNA component (TERC) ncRNAs, reviewed elsewhere [80,143],
we will focus on other classes of ncRNAs, only recently
investigated.
5.1. G-quadruplexes in long non-coding RNAs
A recent bioinformatics survey mapped the distribution of
G-quadruplexes in human ncRNAs of various sizes [144]. It was
found that 749 unique ncRNAs in the human genome (0.59% out
of 126406 ncRNAs annotated in the hg18 human genome assembly
as reported in UCSC genome browser) are predicted to have at least
one G-quadruplex. Particularly, long non-coding RNAs (lncRNAs)
ranging from 200 to 300 nucleotides (nt) in size are enriched in
G-quadruplex motifs, especially those with single or dinucleotide
loops, suggesting that lncRNAs may form highly stable
G-quadruplex structures that regulate their functions in vivo
[144]. Considering the pervasive transcription that leads to expres-
sion, in a very tissue-speciﬁc manner, of a multitude of lncRNAs in
the human genome, the presence of G-quadruplexes, in lncRNA
transcripts or in their cis-regulatory elements, might have impor-
tant implications for their in vivo regulation. Amongst the rapidly
growing list of lncRNA online resources, the LncRNome database
allows users to search for the occurrence of speciﬁc sequence
motifs, such as G-quadruplex forming sequences, within their tran-
scripts (http://genome.igib.res.in/lncRNome/).
5.2. G-quadruplexes in microRNAs
MicroRNAs (miRNAs) represent another important category of
ncRNAs with roles in controlling development, differentiation
and homeostasis. Mature miRNAs are 18–24 nt in size, but are ini-
tially transcribed by RNA polymerase II into a primary transcript
(pri-miRNA) several kb in length. Biogenesis of the majority of
miRNAs follows a ‘‘canonical pathway’’ composed of two distinct
nuclear and cytoplasmic events. Processing of pri-miRNAs takes
place within the nucleus, through an endonucleolytic cleavage by
the RNAse III Drosha [149], as part of the Microprocessor complex
composed also of the DiGeorge syndrome critical region gene 8
(DGCR8) protein, that facilitates the recognition of a 2 nt
30-overhang and a stem of 33 bp within the pri-miRNA [150]
(Fig. 4A). Drosha cleaves the substrate at 11 bp from the base of
the stem, thereby releasing a small hairpin termed a pre-miRNA
[151]. The pre-miRNA hairpin is then bound by the nuclear export
factor Exportin-5 in complex with the GTP bound form of the
cofactor Ran and released into the cytoplasm [152]. Once in the
cytoplasm, the pre-miRNA hairpin is further cleaved by Dicer into
22 nt miRNA duplexes, and loaded onto an Argonaute (Ago)
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(RISC) [153,154]. One strand of the duplex remains loaded onto
Ago as a mature miRNA (the so called guide strand, or miRNA),
whereas the other strand (the passenger strand or miRNA⁄) is usu-
ally degraded by the endonucleolytic activity of Ago proteins [155].
Strikingly, 126 human miRNA genes (about 7% of the
human miRNAs reported in mirBASE when the study was
published) are predicted to contain putative G-quadruplex motifs
in their promoters [156] (http://tubic.tju.edu.cn/greglist), suggest-
ing G-quadruplexes could play a role in regulating the expression
of these miRNAs (Fig. 4A). Furthermore, G-quadruplexes are found
not only within miRNA promoters but also within the miRNA tran-
script. In a recent study Arachchilage and colleagues [145]
observed that 298 out of 1881 human pre-miRNAs annotated in
mirBASE (release 21, June 2014) contain potential G-quadruplex
motifs within their transcript, with a high predictive score. Since
canonical stem-loop structures represent a universal feature pre-
sent in all known pre-miRNAs, essential for their maturation, the
authors hypothesized that G-quadruplexes might co-exist in equi-
librium with stem-loop structures and thus affect stem-loop pro-
cessing by Dicer. They focused on pre-mir 92b, a miRNA involved
in the development of intermediate cortical neuron progenitors
[157] that is also responsible for reducing Smad3 expression in
glioblastomas [158]. By RNAse T1 mapping, gel shift assay and
CD spectroscopy, pre-miRNA 92b was shown to be in equilibrium
between a stem-loop and a G-quadruplex structure, in a K+ ion
dependent manner [145]. The G-quadruplex, in the presence of
potassium, inhibited Dicer-mediated cleavage in an in vitro matu-
ration assay (Fig. 4C), which did not occur in presence of lithium.
G-quadruplex structure formation also inhibited maturation of
miRNA-92b and target silencing in cells [145], providing strong
evidence of the in vivo relevance of the G-quadruplexes in regulat-
ing miRNA function.
Another recent study [146] highlighted the importance of
G-quadruplexes in the reversible inhibition of a target gene by
miRNA-125a. MiRNA-125a has been shown to be critically
involved in regulating the local translation of the post-synaptic
density protein PSD-95, one of the dendritic mRNA targets of
FMRP [159]. A complex between FMRP, Argonaute2 (AGO2) and
mir-125a assembles on the PSD-95 30-UTR when FMRP is phospho-
rylated on Ser499, leading to silencing of PSD-95 protein in den-
drites [159] (Fig. 3B). In response to mGluR signalling, FMRP is
dephosphorylated and releases AGO2 from the complex leading
to derepression of PSD-95 translation [159]. The miR-125a binding
site on PSD-95 mRNA is embedded in the G-rich region bound by
FMRP and predicted to adopt one or more G-quadruplex structures
(Fig. 4B). Stefanovic and colleagues [146] found that the
miRNA-125a target region folds into alternate parallel
G-quadruplex conformations, which coexist in equilibrium. Only
one G-quadruplex conformation leaves the complete miRNA bind-
ing site exposed as a single strand region. MiRNA-125a is able to
target the PSD-95 30-UTR complementary region through canonical
Watson–Crick base-pairing, leaving intact a distal G-quadruplex
structure [146] (Fig. 4B). Because FMRP is able to bind
G-quadruplex motifs [110], the spatial proximity of the distal
G-quadruplex next to the miRNA-125a seeding region might offer
a plausible explanation for the FMRP-mediated assembly of the
RISC complex responsible for miRNA-125a guided PSD-95 silenc-
ing. Stefanovic et al. [146] provide evidence suggesting a novel
mechanism for alternative G-quadruplex structures being able to
regulate accessibility of miRNAs to their targets.
More speculatively, it is also possible that G-quadru
plex-mediated regulation of miRNA biogenesis plays a role in the
pathogenesis of neurodegenerative disease. Speciﬁcally, expansion
of putative G-quadruplex-forming GGCCTG repeats in the ﬁrst
intron of the NOP56 gene has been found in familial cases ofspinocerebellar ataxia type 36 (SCA36). Strikingly, repeat expan-
sion does not result in any change of NOP56 expression, splicing
or its normal localisation to nuclear Cajal bodies in
patient-derived cells, suggesting that haploinsufﬁciency is unlikely
to explain the SCA36 phenotype [64]. Interestingly, the authors
reported that the expanded GGCCTG repeat induced a signiﬁcant
change in the expression of both precursor and mature Mir-1292,
located just 19 bp downstream of the repeat, and proposed that
this might lead to upregulation of glutamate receptors in particular
cell types, resulting in compromised signal transduction and exci-
totoxicity [64]. One possibility is that the GGCCTG repeat forms
G-quadruplexes that impact Mir-1292 transcription, however,
there is currently no direct evidence to support G-quadruplex
formation.
5.3. G-quadruplexes in PIWI-interacting RNAs
A separate class of small non-coding RNAs, known as
PIWI-interacting RNAs (piRNAs) were recently shown to have
G-quadruplex motifs in their transcripts [147] (Fig. 5A). Mature
piRNAs are 23–30 nucleotide long RNAs that bind to PIWI proteins
to form PIWI-ribonucleoprotein particles (piRNP), which are pri-
marily involved in the epigenetic silencing of transposons in the
germline of metazoans, as extensively reviewed in [160]. More
recently a subset of piRNAs have been found that are also
expressed in somatic cells [161] and strikingly in the central ner-
vous system of Aplysia [162], Drosophila melanogaster [163] and
in mouse hippocampus [164]. Primary piRNAs are produced in a
stepwise process. A ﬁrst endonucleolytic cleavage, most likely
mediated by PLD6, generates piRNA precursor intermediate frag-
ments (PPIFs), which are loaded onto PIWI proteins that stabilize
their 50-ends [165,166] (Fig. 5B). The second step is 50-to-30 exonu-
cleolytic trimming by an as yet unidentiﬁed nuclease [167].
Precursor piRNA trimming proceeds until it is sterically hindered
by the loaded PIWI proteins, and it is functionally coupled with
20-O methylation at the 30-end by Hen1 [168]. Recently another
protein, the RNA helicase MOV10L1 was found to mediate an early
step in the piRNA biogenesis [169]. MOV10L1 selectively binds to
G-quadruplex motifs within precursor piRNAs and resolves them
in an ATP-dependent manner, to render their structure accessible
to the endonuclease which catalyzes the ﬁrst step of piRNA pro-
cessing to generate PPIF intermediate fragments [147] (Fig. 5B).
G-quadruplexes may therefore act to regulate piRNA processing.6. Therapeutic approaches targeting G-quadruplexes in
neurodegenerative diseases
Current strategies to tackle neurodegenerative diseases linked
to expanded G-quadruplexes include antisense-mediated interven-
tions and small-molecule based approaches. These approaches are
especially suitable in the case of diseases with a gain-of-function
mechanism, as has been proposed for C9orf72 [90], as by targeting
the primary defect, knowledge of the downstream pathogenic
mechanisms are not required. Antisense oligonucleotides (ASOs)
targeting C9orf72 RNA either within or outside the G-quadruplex
forming GGGGCC repeat region have successfully lowered toxicity
in cellular models of C9orf72 repeat expansion [83,84,88]. ASOs
have also been used previously to restore a normal phenotype in
other neurodegenerative diseases characterized by
gain-of-function mechanisms without involvement of G-quadrup
lexes [170–173].
The presence of expanded G-quadruplexes in speciﬁc neurolog-
ical disorders offers a second approach that utilises small-molecule
ligands directly targeting the speciﬁc G-quadruplex structure
involved. Over one thousand different G-quadruplex ligands have
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chemotypes, generally rich in aromatic rings that enable stacking
with the planar terminal tetrads, as exempliﬁed by the crystal
structure of the human telomeric G-quadruplex in complex with
the ligand BRACO19 [174]. One potential issue for this approach
is whether G-quadruplex-binding ligands can achieve sufﬁcient
speciﬁcity. This implies that each small-molecule could potentiallyrecognise a unique G-quadruplex conformation in the human gen-
ome. G-quadruplexes present variation in their primary sequence,
loop length, nucleic acid strand stoichiometry and orientation and
thermodynamic stability, suggesting a high probability of struc-
tural uniqueness. While structural studies provide evidence that
this is likely to be the case, to date no ligands have been reported
to have 100% speciﬁcity for a single G-quadruplex sequence
1664 R. Simone et al. / FEBS Letters 589 (2015) 1653–1668[175,176]. A useful resource of information listing most of the
known G-quadruplex-binding ligands can be consulted online at
www.g4ldb.org.
Recently two studies have explored this strategy of
conformation-dependent ligands to tackle C9FTD/ALS. A recent
paper by Zamiri et al. [177] found that TMPyP4, a cationic por-
phyrin known to bind G-quadruplexes is able to bind the C9orf72
G4C2 repeat and distort its structure, diminishing its interactions
with hnRNPA1 and SF2 proteins. This study established an impor-
tant proof of principle that G-quadruplex-binding small-molecule
ligands can be used to target the expanded C9orf72 G4C2 repeats
[177]. Similarly Su and colleagues [178] identiﬁed lead
small-molecules targeting the G4C2 repeats that were able to
decrease both RAN translation and RNA foci in both transfected
cultured cells and neurons derived from patients carrying the
repeat expansion. These studies indicate that small molecules tar-
geting G4C2 RNA repeats are a viable therapeutic strategy.
7. Conclusion
G-quadruplexes have long been studied in vitro. Convincing evi-
dence now supports their existence in vivo, and furthermore that
they play important roles both in the normal physiology of the cell
and in disease. The emerging role of G-quadruplexes in neurode-
generative diseases highlights their importance to normal neu-
ronal function and also raises possibilities for therapeutic
intervention. Many studies are bringing to light a multitude of dif-
ferent mechanisms through which ncRNAs operate within cells
and cause dysfunction in disease; mounting evidence for a link
between G-quadruplexes and ncRNAs promises that this will be
an exciting future area of investigation.
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